Findings

What do systematic reviews say?

65 questions · 65 findings · 8 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 16 · 24.6%GRADE not reported 9 · 13.8%Very low 16 · 24.6%Low 7 · 10.8%Moderate 16 · 24.6%High 1 · 1.5%

1% pimecrolimus cream vs betamethasone 17‐valerate 0.1%

Relapse · people with discoid lupus erythematosus

The review found no eligible studies for this question.

1 finding from 1 review

Drugs for discoid lupus erythematosus 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

1% pimecrolimus cream vs betamethasone 17‐valerate 0.1%

Adverse events of medication, leading to discontinuation or significant morbidity · people with discoid lupus erythematosus

The review found no eligible studies for this question.

1 finding from 1 review

Drugs for discoid lupus erythematosus 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ambroxol vs corticosteroid (betamethasone)

Incidence of RDS frequency in newborns · women at risk of preterm birth

Ambroxol showed no clear difference in incidence of RDS frequency in newborns compared with corticosteroid (betamethasone) (moderate certainty).

1 finding from 1 review

Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome 2014 · Cochrane Headline outcomes only
RR 0.79 [0.59, 1.07]
7 studies · 758 participants
Moderate

Ambroxol vs corticosteroid (betamethasone)

Perinatal mortality frequency of deaths of newborns · women at risk of preterm birth

Ambroxol showed no clear difference in perinatal mortality frequency of deaths of newborns compared with corticosteroid (betamethasone) (moderate certainty).

1 finding from 1 review

Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome 2014 · Cochrane Headline outcomes only
RR 0.51 [0.23, 1.12]
6 studies · 657 participants
Moderate

Ambroxol vs corticosteroid (betamethasone)

Adverse effects in pregnant women frequency in pregnant women · women at risk of preterm birth

It is very uncertain whether ambroxol changes adverse effects in pregnant women frequency in pregnant women compared with corticosteroid (betamethasone) (very low certainty).

1 finding from 1 review

Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome 2014 · Cochrane Headline outcomes only
RR 3.45 [0.34, 35.51]
3 studies · 305 participants
Very low